United States (US) Shingles Vaccine Market (2025-2031) | Size & Revenue, Industry, Companies, Competitive Landscape, Value, Segmentation, Trends, Share, Growth, Outlook, Forecast, Analysis

Name: United States (US) Shingles Vaccine Market (2025-2031) | Size & Revenue
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Product (Shingrix, Zostavax, SKYZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine) And Competitive Landscape

Product Code: ETC9976125	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Shingles Vaccine Market Outlook
Market Size of United States (US) Shingles Vaccine Market, 2024
Forecast of United States (US) Shingles Vaccine Market, 2031
Historical Data and Forecast of United States (US) Shingles Vaccine Revenues & Volume for the Period 2021- 2031
United States (US) Shingles Vaccine Market Trend Evolution
United States (US) Shingles Vaccine Market Drivers and Challenges
United States (US) Shingles Vaccine Price Trends
United States (US) Shingles Vaccine Porter's Five Forces
United States (US) Shingles Vaccine Industry Life Cycle
Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Product for the Period 2021- 2031
Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Shingrix for the Period 2021- 2031
Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Zostavax for the Period 2021- 2031
Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By SKYZoster for the Period 2021- 2031
Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Vaccine Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Recombinant Vaccine for the Period 2021- 2031
Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Live Attenuated Vaccine for the Period 2021- 2031
United States (US) Shingles Vaccine Import Export Trade Statistics
Market Opportunity Assessment By Product
Market Opportunity Assessment By Vaccine Type
United States (US) Shingles Vaccine Top Companies Market Share
United States (US) Shingles Vaccine Competitive Benchmarking By Technical and Operational Parameters
United States (US) Shingles Vaccine Company Profiles
United States (US) Shingles Vaccine Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Shingles Vaccine Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Shingles Vaccine Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Shingles Vaccine Market - Industry Life Cycle

3.4 United States (US) Shingles Vaccine Market - Porter's Five Forces

3.5 United States (US) Shingles Vaccine Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) Shingles Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F

4 United States (US) Shingles Vaccine Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing geriatric population in the US

4.2.2 Growing awareness about the importance of vaccination

4.2.3 Rising prevalence of shingles cases in the US

4.3 Market Restraints

4.3.1 High cost of shingles vaccines

4.3.2 Limited access to healthcare services in certain regions

4.3.3 Potential side effects associated with shingles vaccines

5 United States (US) Shingles Vaccine Market Trends

6 United States (US) Shingles Vaccine Market, By Types

6.1 United States (US) Shingles Vaccine Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) Shingles Vaccine Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) Shingles Vaccine Market Revenues & Volume, By Shingrix, 2021- 2031F

6.1.4 United States (US) Shingles Vaccine Market Revenues & Volume, By Zostavax, 2021- 2031F

6.1.5 United States (US) Shingles Vaccine Market Revenues & Volume, By SKYZoster, 2021- 2031F

6.2 United States (US) Shingles Vaccine Market, By Vaccine Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Shingles Vaccine Market Revenues & Volume, By Recombinant Vaccine, 2021- 2031F

6.2.3 United States (US) Shingles Vaccine Market Revenues & Volume, By Live Attenuated Vaccine, 2021- 2031F

7 United States (US) Shingles Vaccine Market Import-Export Trade Statistics

7.1 United States (US) Shingles Vaccine Market Export to Major Countries

7.2 United States (US) Shingles Vaccine Market Imports from Major Countries

8 United States (US) Shingles Vaccine Market Key Performance Indicators

8.1 Vaccination coverage rate among the elderly population in the US

8.2 Number of healthcare providers offering shingles vaccination services

8.3 Research and development investment in new shingles vaccine technologies

8.4 Rate of adverse reactions reported post-shingles vaccination

8.5 Public health campaigns' effectiveness in promoting shingles vaccination

9 United States (US) Shingles Vaccine Market - Opportunity Assessment

9.1 United States (US) Shingles Vaccine Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) Shingles Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F

10 United States (US) Shingles Vaccine Market - Competitive Landscape

10.1 United States (US) Shingles Vaccine Market Revenue Share, By Companies, 2024

10.2 United States (US) Shingles Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Shingles Vaccine Market

El Salvador Shingles Vaccine Market

Equatorial Guinea Shingles Vaccine Market

Eritrea Shingles Vaccine Market

Estonia Shingles Vaccine Market

Ethiopia Shingles Vaccine Market

Global Shingles Vaccine Market

Middle East Shingles Vaccine Market

North America Shingles Vaccine Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here